Ascend Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-246,707
Closed -$22.9M 224
2017
Q4
$22.9M Buy
246,707
+87,353
+55% +$7.94M 0.86% 38
2017
Q3
$14.4M Sell
159,354
-102,477
-39% -$8.72M 0.54% 61
2017
Q2
$22M Buy
261,831
+83,410
+47% +$6.72M 1.02% 32
2017
Q1
$14.4M Buy
+178,421
New +$14M 0.65% 58
2016
Q4
Sell
-282,200
Closed -$19.1M 146
2016
Q3
$19.1M Buy
+282,200
New +$18.9M 1.17% 27
2016
Q2
Sell
-85,038
Closed -$6.14M 152
2016
Q1
$6.14M Buy
+85,038
New +$5.57M 0.59% 62
2015
Q4
Sell
-480,760
Closed -$31.1M 155
2015
Q3
$31.1M Buy
480,760
+222,754
+86% +$16.4M 1.22% 30
2015
Q2
$21.1M Buy
258,006
+176,760
+218% +$13.6M 0.69% 54
2015
Q1
$5.63M Buy
+81,246
New +$5.87M 0.19% 108
2014
Q4
Sell
-615,075
Closed -$49.8M 174
2014
Q3
$49.8M Buy
+615,075
New +$51.3M 1.47% 9
2014
Q2
Sell
-69,804
Closed -$6.02M 184
2014
Q1
$6.02M Buy
69,804
+49,599
+245% +$4.07M 0.16% 134
2013
Q4
$1.63M Buy
+20,205
New +$1.57M 0.05% 170

Other funds holding EMN

Ascend Capital's EMN Position: Q1 2018 in Review

Ascend Capital sold out of Eastman Chemical (EMN) in Q1 2018, closing a stake of 246,707 shares — an estimated $22.9M sold.

Ascend Capital first reported a position in EMN in Q4 2013 and held it in 12 quarters. The position peaked at $49.8M in Q3 2014. 703 funds tracked by Wall St. Rank hold EMN as of Q1 2018.

  • Ascend Capital reported no remaining Eastman Chemical position as of Q1 2018 after selling out during the quarter.
  • Ascend Capital sold 246,707 Eastman Chemical shares in Q1 2018, an estimated $22.9M.
  • Ascend Capital first reported a position in Eastman Chemical in Q4 2013 and held it in 12 quarters.
  • Ascend Capital's Eastman Chemical position peaked at $49.8M in Q3 2014.
  • 703 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.